Venus Concept Ltd Becomes the First and Only Company to Receive FDA Clearance for the use of Magnets in Aesthetic Medicine
Toronto, Canada (March 8, 2012) -- Venus Concept today announces that it has received FDA clearance for the use of PMF (Pulsed Magnetic Fields) combined with 3D bi-polar RF energy matrix as part of its patented (MP) 2 technologies.(MP)2 technology uses proprietary algorithms to combine these two powerful energies. Clinically proven, this dense energy matrix penetrates multiple layers of skin. Complete skin penetration dramatically improves clinical efficacy and produces immediate visible results.
Domenic Serafino, CEO of Venus Concept stated, “We are extremely pleased with this clearance as it establishes a solid baseline for our core technology. This clearance allows us to continue to build upon our strong momentum. Customer acceptance of our unique business model and technology continues to validate that we understand the needs of core and noncore physicians alike”
Venus is a visionary company that defies convention stated Oded Ron-Edoute, Chairman of the company and added “Today’s announcement is extremely exciting. We can now continue delivering on the promise of a more effective, pleasant and profitable experience with our full line of current and future products. Our mandate continues to be to provide the medical community with new and innovative ways to treat patients in a safe and cost effective way.”
Venus Concept will present its full range of products at the upcoming American Academy of Dermatology conference in San Diego from March 17th to 20th, 2012. Please feel free to visit us at booth # 951.
Founded in 2009, Venus Concept devices incorporate the company’s proprietary (MP)2 technology that provides physicians the ability to treat patients safely, predictably and in a PAIN FREE manner. Never before has a company created a mission based on delivering 100% comfort to the patient and a business model that creates financial profitability to the physician.
For further information contact:
Domenic Serafino, CEO